Biodel (BIOD)
Biodel Cash and ST Investments: 31.40M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BIOD Cash and ST Investments Rankings
| Overall | 31st percentile | 2996 of 4365 |
| Sector | 36th percentile | 318 of 504 in Healthcare |
| Industry | 23rd percentile | 30 of 39 in Drug Manufacturers - Other |
BIOD Cash and ST Investments Range, Past 5 Years
| Minimum | 17.62M | Mar 2011 |
| Maximum | 111.69M | Mar 2008 |
| Average | 55.89M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these BIOD related companies
BIOD News
$BIOD http://stks.co/3zVn 4HR view; 10 ready to cross 50, needs to break into the kumo
about 2 days ago by Tr8r_x
about 2 days ago by Tr8r_x
$BIOD http://stks.co/3yiM Battling the 200 day, 10, 50 & 200 converging
about 3 days ago by Tr8r_x
about 3 days ago by Tr8r_x
Biodel Announces Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
May 10, 3:32PM PR Newswire
May 10, 3:32PM PR Newswire
Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
May 07, 6:00AM PR Newswire
May 07, 6:00AM PR Newswire
$BIOD is being mentioned 23x the normal amount on Stocktwits 4,445.5% increase in mentions
about 31 days ago by TradeIdeas1
about 31 days ago by TradeIdeas1
$BIOD just hit $1...the strength that this stock has shown since Monday is incredible...Interesting to see how much it has left
about 31 days ago by investorgadget
about 31 days ago by investorgadget
@oliveblakcok speaking of pump $BIOD yea right LOL speaking of timber next i guess
about 32 days ago by biotech
about 32 days ago by biotech
$cycc too bad you keep pumping this crap...you could have been in $biod
about 32 days ago by oliveblakcok
about 32 days ago by oliveblakcok
Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today
Mar 14, 4:00PM PR Newswire
Mar 14, 4:00PM PR Newswire
Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
Mar 08, 6:00AM PR Newswire
Mar 08, 6:00AM PR Newswire
Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012
Feb 03, 6:59AM PR Newswire
Feb 03, 6:59AM PR Newswire
Biodel (BIOD) Gets Orphan Designation Suggestion from EMA COMP for CHI Treatment Glucagon
Jan 20, 7:04AM Street Insider
Jan 20, 7:04AM Street Insider
Biodel Inc. to Present at 30th Annual JPMorgan Healthcare Conference on January 12th, 2012
Jan 06, 6:59AM PR Newswire
Jan 06, 6:59AM PR Newswire
Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
Dec 01, 4:00PM PR Newswire
Dec 01, 4:00PM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BIOD | 0.76 | +0.01 | +1.47% | 29.42M |
| BSI | 2.555 | +0.01 | +0.59% | 168.60M |
| BSFT | 25.65 | -0.51 | -1.95% | 704.35M |
| BSET | 9.48 | -0.22 | -2.27% | 106.84M |
| BSDM | 1.88 | -0.09 | -4.57% | 55.76M |
| BSD | 14.38 | -0.00 | -0.02% | |
| BSBR | 7.90 | +0.08 | +1.02% | 16.66B |
| BRY | 38.73 | +0.48 | +1.25% | 2.089B |
| BRT | 7.05 | +0.00 | +0.00% | 99.26M |
| BRS | 43.38 | -0.33 | -0.76% | 1.548B |
